Uploaded August 2026 | Updated September 2026, 2 weeks ago
Dr. Bonni Goldstein (Goldstein Wellness) presents "Cannabinoids and the Immune System: Therapeutic Approaches to Autoimmune Disorders" at CannMed 2026, covering inflammatory bowel disease and multiple sclerosis.
This presentation examines the immunomodulatory effects of cannabinoids and their potential role in managing autoimmune diseases. Clinicians will review current evidence on how the endocannabinoid system influences immune regulation, inflammation, and cellular signaling, with discussion of clinical applications in conditions such as inflammatory bowel disease and multiple sclerosis. Practical considerations for integrating cannabinoid-based therapies into patient care will also be addressed.
Dr. Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a leading cannabis medicine specialty practice, and the CEO of GoldsteinWellness.com.
This talk was part of the CannMed Medical Practicum, a full-day educational program for clinicians and professionals expanding their expertise in medical cannabis, covering the endocannabinoid system, cannabinoid therapeutics, minor cannabinoids, product formulation, and more, led by a faculty of internationally recognized physicians and researchers.
This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.
Dr. Bonni Goldstein (Goldstein Wellness) presents "Cannabinoids and the Immune System: Therapeutic Approaches to Autoimmune Disorders" at CannMed 2026, covering inflammatory bowel disease and multiple sclerosis.
This presentation examines the immunomodulatory effects of cannabinoids and their potential role in managing autoimmune diseases. Clinicians will review current evidence on how the endocannabinoid system influences immune regulation, inflammation, and cellular signaling, with discussion of clinical applications in conditions such as inflammatory bowel disease and multiple sclerosis. Practical considerations for integrating cannabinoid-based therapies into patient care will also be addressed.
Dr. Bonni Goldstein, MD is the Medical Director of Canna-Centers Wellness & Education, a leading cannabis medicine specialty practice, and the CEO of GoldsteinWellness.com.
This talk was part of the CannMed Medical Practicum, a full-day educational program for clinicians and professionals expanding their expertise in medical cannabis, covering the endocannabinoid system, cannabinoid therapeutics, minor cannabinoids, product formulation, and more, led by a faculty of internationally recognized physicians and researchers.
This presentation was given at the CannMed 2026 Innovation & Collaboration Summit, held June 15-18 at the Hyatt Regency Lake Tahoe Resort. Visit cannmedevents.com to learn more.
